Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
  • Home
  • /
  • Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
  1. Home /
  2. Archives /
  3. Vol. 36 (2024) /
  4. Medical Sciences

Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids

Authors

  • Tomasz Maciejczyk Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0005-2517-2508
  • Jakub Sadowski Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0005-2259-0958
  • Antoni Sieńko Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0001-6753-7895
  • Małgorzata Łabuś Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0003-2799-4375
  • Julia Dołęga Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0001-0176-7145
  • Piotr Mól The Sergeant Grzegorz Załoga Hospital of the Ministry of the Interior and Administration, st. Wita Stwosza 39-41, 40-042 Katowice, Poland https://orcid.org/0009-0006-8007-1934
  • Bartłomiej Zabawa Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0005-2419-4748
  • Patrycja Hudzińska Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0000-5881-0733
  • Łukasz Stanisław Papież Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0000-1235-0057
  • Karol Krzykawski Faculty of Medical Sciences in Katowice, Medical University of Silesia https://orcid.org/0009-0007-4497-2927

DOI:

https://doi.org/10.12775/QS.2024.36.56580

Keywords

physical activity, hormones, women’s health, menstrual cycle, hrt, anabolic steroids

Abstract

Introduction: Hormones influence women's health and athletic performance, managing conditions like menstrual irregularities, menopause, and osteoporosis. Therapies such as oral contraceptives and IUDs benefit millions but pose risks like breast cancer and cardiovascular events. In sports, hormonal fluctuations affect performance, with steroid abuse raising concerns. This review examines their benefits, risks, and implications.

Materials and Methods: The study conducted a systematic review of the literature, utilizing databases including PubMed, NCBI, and Google Scholar. Data were obtained from clinical and experimental studies and evaluated based on methodological rigor, participant characteristics, and therapeutic outcomes. Articles lacking full-text access were excluded from the analysis.

State of knowledge: Hormones profoundly influence women's health and athletic performance, affecting the menstrual cycle, menopause, and responses to exercise. Physical activity improves cardiovascular and metabolic health but can disrupt hormonal balance with intense training. Hormonal contraceptives, anabolic steroids, and HRT impact health and performance, necessitating individualized approaches and further research.

Conclusions: Hormonal balance is vital for women's health and performance. Physical activity, contraception, and HRT have benefits but require tailored approaches to mitigate risks.

References

Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle

regularization in abnormal uterine bleeding - ovulation dysfunction patients. World J Clin Cases.

;8(15):3259-3266. doi:10.12998/wjcc.v8.i15.3259

Elmaoğulları S, Aycan Z. Abnormal Uterine Bleeding in Adolescents. J Clin Res Pediatr Endocrinol.

;10(3):191-197. doi:10.4274/jcrpe.0014

Sachedina A, Todd N. Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents. J Clin

Res Pediatr Endocrinol. 2020;12(Suppl 1):7-17. doi:10.4274/jcrpe.galenos.2019.2019.S0217

Hee L, Kettner LO, Vejtorp M. Continuous use of oral contraceptives: an overview of effects and

side-effects. Acta Obstet Gynecol Scand. 2013;92(2):125-136. doi:10.1111/aogs.12036

Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause

Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022;28(3):208-223.

doi:10.1097/PPO.0000000000000591

Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS

teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med

Pharmacol Sci. 2021;25(23):7476-7485. doi:10.26355/eurrev_202112_27447

Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary Hormonal

Contraception and the Risk of Breast Cancer. N Engl J Med. 2017;377(23):2228-2239.

doi:10.1056/NEJMoa1700732

Cho L, Kaunitz AM, Faubion SS, et al. Rethinking Menopausal Hormone Therapy: For Whom, What,

When, and How Long?. Circulation. 2023;147(7):597-610.

doi:10.1161/CIRCULATIONAHA.122.061559

Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral

contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev.

;2015(8):CD011054. Published 2015 Aug 27. doi:10.1002/14651858.CD011054.pub2

Huang G, Basaria S. Do anabolic-androgenic steroids have performance-enhancing effects in female

athletes?. Mol Cell Endocrinol. 2018;464:56-64. doi:10.1016/j.mce.2017.07.010

Palacios S, Colli E, Regidor PA. Multicenter, phase III trials on the contraceptive efficacy, tolerability

and safety of a new drospirenone-only pill. Acta Obstet Gynecol Scand. 2019;98(12):1549-1557.

doi:10.1111/aogs.13688

Collaborative Group On Epidemiological Studies Of Ovarian Cancer, Beral V, Gaitskell K, et al.

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52

epidemiological studies. Lancet. 2015;385(9980):1835-1842. doi:10.1016/S0140-6736(14)61687-1

Haakenstad A, Angelino O, Irvine CMS, et al. Measuring contraceptive method mix, prevalence, and

demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic

analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10348):295-327.

doi:10.1016/S0140-6736(22)00936-9

MacGregor KA, Gallagher IJ, Moran CN. Relationship Between Insulin Sensitivity and Menstrual

Cycle Is Modified by BMI, Fitness, and Physical Activity in NHANES. J Clin Endocrinol Metab. 2021

Sep 27;106(10):2979-2990. doi: 10.1210/clinem/dgab415. PMID: 34111293; PMCID: PMC8475204

Tűű L, Nas K, Török M, Várbíró S. SHBG Levels Do Not Correlate with Insulin Levels in PCOS with

Appropriate Fasting Insulin Sensitivity. J Clin Med. 2024 Feb 1;13(3):838. doi: 10.3390/jcm13030838.

PMID: 38337532; PMCID: PMC10856642.

Najmabadi S, Schliep KC, Simonsen SE, Porucznik CA, Egger MJ, Stanford JB. Menstrual bleeding,

cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled

analysis of three cohorts. Paediatr Perinat Epidemiol. 2020 May;34(3):318-327. doi:

1111/ppe.12644. Epub 2020 Feb 27. PMID: 32104920; PMCID: PMC8495765.

Barbu, R. Neurohormonal and pharmacological regulation of oestrogen, progesterone, luteinizing

hormone and follicle stimulating hormone over the menstrual cycle – the possible relevance of

angiontensin ii. 2021. Farmacia, 69(1), 82-89. https://doi.org/10.31925/farmacia.2021.1.11

Monaco CF, Davis JS. Mechanisms of angioregression of the corpus luteum. Front Physiol. 2023 Sep

;14:1254943. doi: 10.3389/fphys.2023.1254943. PMID: 37841308; PMCID: PMC10568036.

Huang G, Bhasin S, Pencina K, Cheng M, Jasuja R. Circulating dihydrotestosterone, testosterone, and

free testosterone levels and dihydrotestosterone-to-testosterone ratios in healthy women across the

menstrual cycle. Fertil Steril. 2022 Dec;118(6):1150-1158. doi: 10.1016/j.fertnstert.2022.09.011. Epub

Nov 9. PMID: 36371319.

Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M. Polycystic Ovary Syndrome:

Etiology, Current Management, and Future Therapeutics. J Clin Med. 2023 Feb 11;12(4):1454. doi:

3390/jcm12041454. PMID: 36835989; PMCID: PMC9964744.

Warren M, Perlroth N. The effects of intense exercise on the female reproductive system. Journal of

Endocrinology. 2001;170(1):3-11. doi:https://doi.org/10.1677/joe.0.1700003

Haddock BL, Hopp Marshak HP, Mason JJ, Blix G. The Effect of Hormone Replacement Therapy and

Exercise on Cardiovascular Disease Risk Factors in Postmenopausal Women. Sports Medicine.

;29(1):39-49. doi:https://doi.org/10.2165/00007256-200029010-00004

Edwards ES, Sackett SC. Psychosocial Variables Related to Why Women are Less Active than Men and

Related Health Implications. Clinical Medicine Insights: Women’s Health.

;9s1(1):CMWH.S34668. doi:https://doi.org/10.4137/cmwh.s34668

Akkurt M, Ökmen MŞ, Polat M. Effects of eight-week aerobic exercises combined with resistance

training on cardiovascular risk factors in women. Biomedical Human Kinetics. 2023;15(1):1-8.

doi:https://doi.org/10.2478/bhk-2023-0001

Orio. Effects of physical exercise on the female reproductive system. Minerva endocrinologica.

;38(3). Accessed November 23, 2024. https://pubmed.ncbi.nlm.nih.gov/24126551

Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased

early insulin secretion after weight loss in obese women with polycystic ovary syndrome. The Journal

of Clinical Endocrinology & Metabolism. 1995;80(9):2586-2593.

doi:https://doi.org/10.1210/jcem.80.9.7673399

Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women

results in improvement in reproductive outcome for all forms of fertility treatment. Human

Reproduction. 1998;13(6):1502-1505. doi:https://doi.org/10.1093/humrep/13.6.1502

Skrzypulec V, Dąbrowska J, Drosdzol A. The influence of physical activity level on climacteric

symptoms in menopausal women. Climacteric. 2010;13(4):355-361.

doi:https://doi.org/10.3109/13697131003597019

Warren MP, Goodman LR. Exercise-induced endocrine pathologies. Journal of Endocrinological

Investigation. 2003;26(9):873-878. doi:https://doi.org/10.1007/bf03345238

Morino S, Hirata H, Matsumoto D, Yokota I, Aoyama T. Patterns of premenstrual syndrome in

collegiate women: A cross-sectional study. Medicine. 2022;101(35):e30186.

doi:https://doi.org/10.1097/md.0000000000030186

Siminiuc R, Ţurcanu D. Impact of nutritional diet therapy on premenstrual syndrome. Frontiers in

Nutrition. 2023;10. doi:https://doi.org/10.3389/fnut.2023.1079417

Anushka Raipure, Patil S. The Role of Benson’s and Mitchell’s Relaxation Techniques in the

Management of Premenstrual Syndrome: An In-Depth Review. Cureus. Published online August 20,

doi:https://doi.org/10.7759/cureus.43822

Zahra Molazem, Alizadeh M, Masoume Rambod. The Effect of Benson’s Relaxation Technique on Pain

Intensity, Belief, Perception, and Acceptance in adult Hemophilia Patients: A Randomized Controlled

Trial. PubMed. 2021;9(3):187-198. doi:https://doi.org/10.30476/ijcbnm.2021.87937.1471

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA. Low-Dose Sertraline in the Treatment

of Moderate-to-Severe Premenstrual Syndrome. The Journal of Clinical Psychiatry.

;67(10):1624-1632. doi:https://doi.org/10.4088/jcp.v67n1020

Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and

premenstrual dysphoric disorder: a systematic review. Archives of Women’s Mental Health.

;20(6):713-719. doi:https://doi.org/10.1007/s00737-017-0791-0

Howard SA, Benhabbour SR. Non-Hormonal Contraception. J Clin Med. 2023 Jul 20;12(14):4791. doi:

3390/jcm12144791. PMID: 37510905; PMCID: PMC10381146.

Kerscher M, Reuther T, Krueger N, Buntrock H. Effects of an oral contraceptive containing

chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal

contraception. J Eur Acad Dermatol Venereol. 2013 May;27(5):601-8. doi:

1111/j.1468-3083.2012.04497.x. Epub 2012 Mar 10. PMID: 22404700.

Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C. Effects of depot

medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex

hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical

trial. BMC Womens Health. 2024 Mar 8;24(1):167. doi: 10.1186/s12905-024-02990-8. PMID:

; PMCID: PMC10921651.

Le Guen M, Schantz C, Régnier-Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal

contraception in Western countries: A systematic review. Soc Sci Med. 2021 Sep;284:114247. doi:

1016/j.socscimed.2021.114247. Epub 2021 Jul 20. PMID: 34339927.

Han L, Park D, Reddy A, Wilmarth PA, Jensen JT. Comparing endocervical mucus proteome of humans

and rhesus macaques. Proteomics Clin Appl. 2021 Jul;15(4):e2100023. doi: 10.1002/prca.202100023.

Epub 2021 May 26. PMID: 33991406; PMCID: PMC8653767.

Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine

contraceptive devices. Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1263-9. doi:

1016/s0002-9378(99)70120-1. PMID: 10561657.

Cooper DB, Patel P. Oral Contraceptive Pills. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island

(FL): StatPearls Publishing; 2024 Jan–. PMID: 28613632.

Enfield K, Cartwright M, Toit RL, Avenant C, Africander D, Hapgood JP. Characterisation of

progestins used in hormonal contraception and progesterone via the progesterone receptor. Biochem

Biophys Res Commun. 2020 Dec 17;533(4):879-885. doi: 10.1016/j.bbrc.2020.09.058. Epub 2020 Sep

PMID: 33008590; PMCID: PMC8129485.

Grandi G, Farulla A, Sileo FG, Facchinetti F. Levonorgestrel-releasing intra-uterine systems as female

contraceptives. Expert Opin Pharmacother. 2018 May;19(7):677-686. doi:

1080/14656566.2018.1462337. Epub 2018 Apr 11. PMID: 29637798.

Huvinen E, Holopainen E, Heikinheimo O. Norethisterone and its acetate - what's so special about

them? BMJ Sex Reprod Health. 2021 Apr;47(2):102-109. doi: 10.1136/bmjsrh-2020-200619. Epub

May 12. PMID: 32398290.

Rauchenzauner M, Deichmann S, Pittschieler S, Bergmann M, Prieschl M, Unterberger I, Rösing B,

Seger C, Moser C, Wildt L, Luef G. Bidirectional interaction between oral contraception and

lamotrigine in women with epilepsy - Role of progestins. Seizure. 2020 Jan;74:89-92. doi:

1016/j.seizure.2019.11.011. Epub 2019 Nov 25. PMID: 31869755.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child

Health and Human Development; 2006–. Dienogest. 2021 Nov 15. PMID: 30000815.

Vercellini P, Esposito G, Santucci C, Parazzini F, La Vecchia C. Nomegestrol acetate for symptomatic

endometriosis and meningioma risk: understandable statistics for decision-making. Eur J Obstet

Gynecol Reprod Biol. 2023 Jul;286:149-150. doi: 10.1016/j.ejogrb.2023.05.002. Epub 2023 May 6.

PMID: 37183159.

Fu D, Huang J, Li K, Chen Y, He Y, Sun Y, Guo Y, Du L, Qu Q, Miao Y, Hu Z.

Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice

simulates androgenetic alopecia. Biomed Pharmacother. 2021 May;137:111247. doi:

1016/j.biopha.2021.111247. Epub 2021 Jan 29. PMID: 33517191.

Knopp RH, LaRosa JC, Burkman RT Jr. Contraception and dyslipidemia. Am J Obstet Gynecol. 1993

Jun;168(6 Pt 2):1994-2005. doi: 10.1016/s0002-9378(12)90941-2. PMID: 8512044.

Ko SH, Kim HS. Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for

Postmenopausal Women. Nutrients. 2020 Jan 13;12(1):202. doi: 10.3390/nu12010202. PMID:

; PMCID: PMC7019719.

Ng YW, Liang S, Singh K. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho

Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.

Contraception. 2009 Jan;79(1):24-8. doi: 10.1016/j.contraception.2008.07.012. Epub 2008 Sep 18.

PMID: 19041437.

Cockrum RH, Soo J, Ham SA, Cohen KS, Snow SG. Association of Progestogens and Venous

Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 Sep 1;140(3):477-487.

doi: 10.1097/AOG.0000000000004896. Epub 2022 Aug 3. PMID: 35926206; PMCID: PMC9669089.

Creinin MD, Westhoff CL, Bouchard C, Chen MJ, Jensen JT, Kaunitz AM, Achilles SL, Foidart JM,

Archer DF. Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and

safety results. Contraception. 2021 Sep;104(3):222-228. doi: 10.1016/j.contraception.2021.05.002.

Epub 2021 May 15. PMID: 34000251.

Foidart JM. Added benefits of drospirenone for compliance. Climacteric. 2005 Oct;8 Suppl 3:28-34.

doi: 10.1080/13697130500330309. PMID: 16203653.

Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS

teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med

Pharmacol Sci. 2021 Dec;25(23):7476-7485. doi: 10.26355/eurrev_202112_27447. PMID: 34919250.

Foidart JM, Faustmann T. Advances in hormone replacement therapy: weight benefits of drospirenone,

a 17alpha-spirolactone-derived progestogen. Gynecol Endocrinol. 2007 Dec;23(12):692-9. doi:

1080/09513590701582323. PMID: 18075844.

Oxfeldt M, Dalgaard LB, Jørgensen AA, Hansen M. Hormonal Contraceptive Use, Menstrual

Dysfunctions, and Self-Reported Side Effects in Elite Athletes in Denmark. Int J Sports Physiol

Perform. 2020;15(10):1377-1384. Published 2020 Sep 21. doi:10.1123/ijspp.2019-0636

Schaumberg MA, Emmerton LM, Jenkins DG, Burton NW, Janse de Jonge XAK, Skinner TL. Use of

Oral Contraceptives to Manipulate Menstruation in Young, Physically Active Women. Int J Sports

Physiol Perform. 2018;13(1):82-87. doi:10.1123/ijspp.2016-0689

Elliott-Sale KJ, McNulty KL, Ansdell P, et al. The Effects of Oral Contraceptives on Exercise

Performance in Women: A Systematic Review and Meta-analysis. Sports Med. 2020;50(10):1785-1812.

doi:10.1007/s40279-020-01317-5

Wikström-Frisén L, Boraxbekk CJ, Henriksson-Larsén K. Effects on power, strength and lean body

mass of menstrual/oral contraceptive cycle based resistance training. J Sports Med Phys Fitness.

;57(1-2):43-52. doi:10.23736/S0022-4707.16.05848-5

Dragutinovic B, Moser F, Notbohm HL, Ihalainen JK, Bloch W, Schumann M. Influence of menstrual

cycle and oral contraceptive phases on strength performance, neuromuscular fatigue, and perceived

exertion. J Appl Physiol (1985). 2024;137(4):919-933. doi:10.1152/japplphysiol.00198.2024

Nolan D, McNulty KL, Manninen M, Egan B. The Effect of Hormonal Contraceptive Use on Skeletal

Muscle Hypertrophy, Power and Strength Adaptations to Resistance Exercise Training: A Systematic

Review and Multilevel Meta-analysis. Sports Med. 2024;54(1):105-125.

doi:10.1007/s40279-023-01911-3

Piatkowski T, Whiteside B, Robertson J, Henning A, Lau EHY, Dunn M. What is the prevalence of

anabolic-androgenic steroid use among women? A systematic review. Addiction.

;119(12):2088-2100. doi:10.1111/add.16643

Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A. Anabolic-androgenic steroid use among women - A

qualitative study on experiences of masculinizing, gonadal and sexual effects. Int J Drug Policy.

;95:102876. doi:10.1016/j.drugpo.2020.102876

Piatkowski T, Robertson J, Lamon S, Dunn M. Gendered perspectives on women's anabolic-androgenic

steroid (AAS) usage practices. Harm Reduct J. 2023;20(1):56. Published 2023 Apr 25.

doi:10.1186/s12954-023-00786-x

Kim HK, Della-Fera MA, Hausman DB, Baile CA. Effect of clenbuterol on apoptosis, adipogenesis,

and lipolysis in adipocytes. J Physiol Biochem. 2010;66(3):197-203. doi:10.1007/s13105-010-0024-8

Abrahin O, Souza NS, de Sousa EC, Santos AM, Bahrke MS. Anabolic-androgenic steroid use among

Brazilian women: an exploratory investigation. J Subst Use. 2016;22(3):246-252.

doi:10.1080/14659891.2016.1179806.

Huang G, Basaria S, Travison TG, et al. Testosterone dose-response relationships in hysterectomized

women with or without oophorectomy: effects on sexual function, body composition, muscle

performance and physical function in a randomized trial. Menopause. 2014;21(6):612-623.

doi:10.1097/GME.0000000000000093

Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women.

Psychother Psychosom. 2000;69(1):19-26. doi:10.1159/000012362

Nieschlag E, Vorona E. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping

with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol.

;173(2):R47-R58. doi:10.1530/EJE-15-0080

Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained

women athletes. JAMA. 1985;253(19):2871-2873.

Peacock K, Carlson K, Ketvertis KM. Menopause. 2023 Dec 21. In: StatPearls [Internet]. Treasure

Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29939603.

Peycheva D, Sullivan A, Hardy R, Bryson A, Conti G, Ploubidis G. Risk factors for natural menopause

before the age of 45: evidence from two British population-based birth cohort studies. BMC Womens

Health. 2022 Nov 8;22(1):438. doi: 10.1186/s12905-022-02021-4. PMID: 36348338; PMCID:

PMC9644638.

Takahashi TA, Johnson KM. Menopause. Med Clin North Am. 2015 May;99(3):521-34. doi:

1016/j.mcna.2015.01.006. PMID: 25841598.

Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition.

Recent Prog Horm Res. 2002;57:257-75. doi: 10.1210/rp.57.1.257. PMID: 12017547.

Davis SR, Martinez-Garcia A, Robinson PJ, Handelsman DJ, Desai R, Wolfe R, Bell RJ; ASPREE

Investigator Group. Estrone Is a Strong Predictor of Circulating Estradiol in Women Age 70 Years and

Older. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3348–54. doi: 10.1210/clinem/dgaa429. PMID:

; PMCID: PMC7394338.

Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol

Metab Clin North Am. 2015 Sep;44(3):497-515. doi: 10.1016/j.ecl.2015.05.001. PMID: 26316239;

PMCID: PMC4890704.

El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC,

Manson JE, Stefanick ML, Allison MA; American Heart Association Prevention Science Committee of

the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing.

Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention:

A Scientific Statement From the American Heart Association. Circulation. 2020 Dec

;142(25):e506-e532. doi: 10.1161/CIR.0000000000000912. Epub 2020 Nov 30. PMID: 33251828.

WIŚNIEWSKA, Alicja, NAPIERAŁA, Marek, PEZALA, Małgorzata and ZUKOW, Walery. The effect

of physical activity on psychomotor women menopausal. Pedagogy and Psychology of Sport. Online.

November 2015. Vol. 1, no. 1, pp. 41-58. [Accessed 24 November 2024]. DOI

12775/PPS.2015.01.01.004.

Nilsson S, Henriksson M, Hammar M, Berin E, Lawesson SS, Ward LJ, Li W, Holm AS. A 2-year

follow-up to a randomized controlled trial on resistance training in postmenopausal women: vasomotor

symptoms, quality of life and cardiovascular risk markers. BMC Womens Health. 2024 Sep

;24(1):511. doi: 10.1186/s12905-024-03351-1. PMID: 39272114; PMCID: PMC11396825.

Pertyński, Tomasz and Grzegorz Stachowiak. “A standard of oral hormone replacement therapy in

women after menopause – 1 mg of 17β-estradiol plus dydrogesterone?” (2005).

Martino, Pablo. “El rendimiento mnésico en la mujer climatérica: una revisión The memory

performance in the climacteric women: a review.” (2014).

Afaghi S, Rahimi FS, Soltani P, Kiani A, Abedini A. Sex-Specific Differences in Cardiovascular

Adaptations and Risks in Elite Athletes: Bridging the Gap in Sports Cardiology. Clin Cardiol. 2024

Sep;47(9):e70006. doi: 10.1002/clc.70006. PMID: 39228309; PMCID: PMC11372237.

Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause

Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022 May-Jun

;28(3):208-223. doi: 10.1097/PPO.0000000000000591. PMID: 35594469; PMCID: PMC9178928.

Dadgostar H, Soleimany G, Movaseghi S, Dadgostar E, Lotfian S. The effect of hormone therapy on

bone mineral density and cardiovascular factors among Iranian female athletes with

amenorrhea/oligomenorrhea: A randomized clinical trial. Med J Islam Repub Iran. 2018 Apr 1;32:27.

doi: 10.14196/mjiri.32.27. PMID: 30159278; PMCID: PMC6108246.

Rahnama, Mansur et al. “Influence of hormone replacement therapy on the level of alkaline

phosphatase and acid phosphatase in serum and saliva among women with estrogen deficiency.” (2012).

Hagmar, Magnus. “Menstrual status and long-term cardiovascular effects of intense exercise in top elite

athlete women.” (2008).

Downloads

  • PDF

Published

2024-12-20

How to Cite

1.
MACIEJCZYK, Tomasz, SADOWSKI, Jakub, SIEŃKO, Antoni, ŁABUŚ, Małgorzata, DOŁĘGA, Julia, MÓL, Piotr, ZABAWA, Bartłomiej, HUDZIŃSKA , Patrycja, PAPIEŻ, Łukasz Stanisław and KRZYKAWSKI , Karol. Hormonal Influences on Women’s Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids. Quality in Sport. Online. 20 December 2024. Vol. 36, p. 56580. [Accessed 5 July 2025]. DOI 10.12775/QS.2024.36.56580.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 36 (2024)

Section

Medical Sciences

License

Copyright (c) 2024 Tomasz Maciejczyk, Jakub Sadowski, Antoni Sieńko, Małgorzata Łabuś, Julia Dołęga, Piotr Mól, Bartłomiej Zabawa, Patrycja Hudzińska , Łukasz Stanisław Papież, Karol Krzykawski

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 288
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

physical activity, hormones, women’s health, menstrual cycle, hrt, anabolic steroids
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop